Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).
Logsdon, C. D. et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer (Cancer Research (2003) (2649-2657)). Cancer Res. 63, 3445 (2003).
Maurer, H. C. et al. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes. Gut 68, 1034–1043 (2019).
Wolff, R. A. et al. Dynamic changes during the treatment of pancreatic cancer. Oncotarget 9, 14764–14790 (2018).
Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
Laise, P. et al. Pancreatic ductal adenocarcinoma comprises coexisting regulatory states with both common and distinct dependencies. bioRxiv https://www.biorxiv.org/content/10.1101/2020.10.27.357269v1 (2020).
Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma- specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168–1178 (2015).
Aung, K. L. et al. Genomics-driven precision medicine for advanced pancreatic cancer – early results from the COMPASS trial. Clinical Cancer Res. 24, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968824/ (2017).
Grünwald, B. T. et al. Spatially confined sub-tumor microenvironments orchestrate pancreatic cancer pathobiology. bioRxiv https://www.biorxiv.org/content/10.1101/2021.02.18.431890v1 (2021).
Rashid, N.U. et al. Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer. Clin. Cancer Res. (2019)https://doi.org/10.1158/1078-0432.CCR-19-1467.
Torre-Healy, L. A. et al. Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model. Commun. Biol. 6, 163 (2023).
Whiteside, T. L. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904–5912 (2008).
Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377–382 (2009).
Trapnell, C., Cacchiarelli, D. & Qiu, X. Monocle: cell counting, differential expression, and trajectory analysis for single-cell RNA-Seq experiments. Bioconductor 10 http://bioconductor.org/packages/devel/bioc/vignettes/monocle/inst/doc/monocle-vignette.pdf (2017).
MD, C. et al. A distinct microglial subset at the tumor-stroma interface of glioma. Glia 69, 1767–1781 (2021).
Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293–1308.e36 (2018).
Rao, M. et al. Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis-specific targets in a patient with small intestinal neuroendocrine cancer. Cold Spring Harb. Mol. Case Stud. 6, 1–9 (2020).
Muraro, M. J. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3, 385–394.e3 (2016).
Baron, M. et al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst. 3, 346–360.e4 (2016).
Segerstolpe, Å. et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 24, 593–607 (2016).
Qadir, M. M. F. et al. Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche. Proc. Natl Acad. Sci. USA 117, 10876–10887 (2020).
Öhlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 214, jem.20162024 (2017).
Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102–1123 (2019).
Biffi, G. et al. IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 9, 282–301 (2019).
Chen, K. et al. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression. EBioMedicine 66, 103315 (2021).
Wang, Y. et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 7, 36 (2021).
Zhang, Q. et al. Landscape and dynamics of single immune. Cells 179, 829–845.e20 (2019).
Yang, J. et al. Calcium-binding proteins S100A8 and S100A9: investigation of their immune regulatory effect in myeloid cells. Int J. Mol. Sci. 19, 1833 (2018).
Wu, L. et al. Spatially-resolved transcriptomics analyses of invasive fronts in solid tumors. bioRxiv https://www.biorxiv.org/content/10.1101/2021.10.21.465135v1 (2021).
Lauer, S. J. et al. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263, 7277–7286 (1988).
Quaranta, V. et al. Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Res. 78, 4253–4269 (2018).
Fleming, R. E., Crouch, E. C., Ruzicka, C. A. & Sly, W. S. Pulmonary carbonic anhydrase IV: developmental regulation and cell-specific expression in the capillary endothelium. Am. J. Physiol. 265, L627–L635 (1993).
Thiriot, A. et al. Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues. BMC Biol. 15, 1–19 (2017).
Su, T. et al. Single-cell analysis of early progenitor cells that build coronary arteries. Nature 559, 356–362 (2018).
Stahl, A. et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood 120, 2925 (2012).
Lee, S. et al. Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27. Mol. Cell Biochem. 338, 255–p261 (2010).
Yan, M. et al. Dynamic regulatory networks of T cell trajectory dissect transcriptional control of T cell state transition. Mol. Ther. Nucleic Acids 26, 1115–1129 (2021).
Fei, Q. et al. High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Cell Death Dis. 11, 1–13 (2020).
Ng, S. S. et al. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation. Nat. Immunol. 21, 1205–1218 (2020).
Xiao, Z., Mescher, M. F. & Jameson, S. C. Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J. Exp. Med. 204, 2667–2677 (2007).
Punt, S. et al. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival. Oncotarget 6, 38681–38694 (2015).
Reimold, A. M. et al. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412, 300–307 (2001).
Turnquist, H. R. et al. CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity. Int. J. Oncol. 30, 631–639 (2007).
Binnewies, M. et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep. 37, 109844 (2021).
Zhang, W., Zhang, Y. & Fang, Q. [Effect of Galectin-9/Tim−3 pathway on the polarization of M1/M2 subtype in murine macrophages induced by lipopolysaccharide]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 30, 836–841 (2018).
Tan, Y. & Cahan, P. SingleCellNet: a computational tool to classify single cell RNA-seq data across platforms and across species. Cell Syst. 9, 207–213.e2 (2019).
Yu, X., Zhang, L., Chaudhry, A., Rapaport, A. S. & Ouyang, W. Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis. J. Leukoc. Biol. 107, 917–932 (2020).
Harricharran, T. & Ogunwobi, O. O. Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer. Hepatobiliary Pancreat. Dis. Int. 19, 175–180 (2020).
Raghavan, S. et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 184, 6119–6137.e26 (2021).
Chakraborty, D. et al. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat. Commun. 8, 1–16 (2017).
Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261–268 (2001).
Li, Y. et al. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells. Cancer Lett. 497, 212–220 (2021).
Niu, J. et al. Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-κB transcription factors *. J. Biol. Chem. 282, 6001–6011 (2007).
Imaizumi, T., Yoshida, H. & Satoh, K. Regulation of CX3CL1/fractalkine expression in endothelial cells. J. Atheroscler. Thromb. 11, 15–21 (2004).
Larsen, A. M. H. et al. Collagen density modulates the immunosuppressive functions of macrophages. J. Immunol. 205, 1461–1472 (2020).
Jin-Sung Park, A. et al. Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment. Cancer Cell 30, 953–967 (2016).
Hilton, D. J. LIF: lots of interesting functions. Trends Biochem Sci. 17, 72–76 (1992).
Juiz, N. et al. Basal-like and Classical cells coexistence in pancreatic cancer revealed by single cell analysis. bioRxiv https://doi.org/10.1101/2020.01.07.897454. (2020).
Sawey, E. T., Johnson, J. A. & Crawford, H. C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc. Natl Acad. Sci. 104, 19327–19332 (2007).
Fukuda, A. et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441 (2011).
Prasad, N. B. et al. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 65, 1619–1626 (2005).
Delecourt, F. PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides. BioRxiv https://doi.org/10.1101/2022.01.04.474951 (2022)
Zhou, D. C. et al. Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer. bioRxiv https://www.biorxiv.org/content/10.1101/2021.01.13.426413v1 (2021).
Steele, N. G. et al. Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer. Clin. Cancer Res. 27, 2023–2037 (2021).
Gu, D., Schlotman, K. E. & Xie, J. Deciphering the role of hedgehog signaling in pancreatic cancer. J. Biomed. Res. 30, 353 (2016).
Colpitts, S. L., Dalton, N. M. & Scott, P. IL-7 receptor expression provides the potential for long-term survival of both CD62L high central memory T cells and Th1 effector cells during leishmania major infection. J. Immunol. 182, 5702–5711 (2009).
Quan, M. Y. et al. An FGFR/AKT/SOX2 signaling axis controls pancreatic cancer stemness. Front. Cell Dev. Biol. 8, 287 (2020).
Chenivesse, C. et al. Pulmonary CCL18 recruits human regulatory T cells. J. Immunol. 189, 128–137 (2012).
Espiau-Romera, P., Courtois, S., Parejo-Alonso, B. & Sancho, P. Molecular and metabolic subtypes correspondence for pancreatic ductal adenocarcinoma classification. J. Clin. Med. 9, 1–21 (2020).
Chen, H., Pan, Y., Jin, X. & Chen, G. An immune cell infiltration-related gene signature predicts prognosis for bladder cancer. Sci. Rep. 11, 1–13 (2021).
Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112–1129 (2018).
Sarai, K. et al. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma. Gut 68, 487–498 (2018).
Hayashi, A. et al. A Unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat. Cancer 1, 59–74 (2020).
Williams, H. L. et al. Spatially resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intratumoral heterogeneity. Cancer Res. 83, 441–455 (2023).
Song, J. S. et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc. Natl Acad. Sci. USA 118, e2015433118 (2021).
Santagata, S. et al. CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment. Front. Oncol. 11, 1225 (2021).
Luker, G. D. et al. At the bench: pre-clinical evidence for multiple functions of CXCR4 in cancer. J. Leukoc. Biol. 109, 969–989 (2021).
Cameron, A. M. et al. Inflammatory macrophage dependence on NAD + salvage is a consequence of reactive oxygen species-mediated DNA damage. Nat. Immunol. 20, 420–432 (2019).
Catakovic, K., Klieser, E., Neureiter, D. & Geisberger, R. T cell exhaustion: from pathophysiological basics to tumor immunotherapy. Cell Commun. Signal. 2017 15:1 15, 1–16 (2017).
Ayars, M. et al. IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth. Oncotarget 8, 83370–83383 (2017).
Carter, E. P. et al. Dissecting FGF signalling to target cellular crosstalk in pancreatic cancer. Cells 10, 847 (2021).
Gao, X. et al. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Cancer Lett. 524, 42–56 (2022).
Klussmeier, A., Aurich, S., Niederstadt, L., Wiedenmann, B. & Grötzinger, C. Secretin receptor as a target in gastrointestinal cancer: expression analysis and ligand development. Biomedicines 10, 536 (2022).
Chen, K. et al. Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Cancer Lett. 545, 215834 (2022).
Cheng, M. et al. Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing. J. Cancer Res. Clin. Oncol. 1–16 (2022) https://doi.org/10.1007/S00432-022-04498-W/FIGURES/7.
Waibl Polania, J., Lerner, E. C., Wilkinson, D. S., Hoyt-Miggelbrink, A. & Fecci, P. E. Pushing past the blockade: advancements in T cell-based cancer immunotherapies. Front. Immunol. 12, 4862 (2021).
Xiang, X., Wang, J., Lu, D. & Xu, X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct. Target. Ther. 6, 1–12 (2021).
Abdelfattah, N. et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat. Commun. 13, 1–18 (2022).
Matrisian, L. M. & Berlin, J. D. The past, present, and future of pancreatic cancer clinical trials. Am. Soc. Clin. Oncol. Educ. Book 35, e205–e215 (2016).
Wang-Gillam, A. et al. A randomized phase II study of cabiralizumab (cabira) + nivolumab (nivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC). J. Clin. Oncol. 37, TPS465–TPS465 (2019).
Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442–459.e29 (2020).
Srivastava, A., Malik, L., Smith, T., Sudbery, I. & Patro, R. Alevin efficiently estimates accurate gene abundances from dscRNA-seq data. Genome Biol. 20, 65 (2019).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Alquicira-Hernandez, J. & Powell, J. E. Nebulosa recovers single-cell gene expression signals by kernel density estimation. Bioinformatics 37, 2485–2487 (2021).
Hosein, A. N. et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight 5, e129212 (2019).
Gabitova-Cornell, L. et al. Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer. Cancer Cell 38, 567–583.e11 (2020).
Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1–20 (2021).
Oh, K., et al. Coordinated single cell tumor microenvironment dynamics reinforce pancreatic cancer subtype, scOh, https://doi.org/10.5281/zenodo.8066926, (2023)